Skip to main content
. 2021 Mar 18;7(5):1–8. doi: 10.1001/jamaoncol.2021.0310

Table 1. Baseline Characteristics of Patients.

Characteristic No. (%)
Electroacupuncture (n = 145) Auricular acupuncture (n = 143) Usual care (n = 72)
Age, mean (SD), y 61.9 (13.2) 62.6 (11.3) 61.4 (14.3)
Sex
Male 43 (29.7) 49 (34.3) 17 (23.6)
Female 102 (70.3) 94 (65.7) 55 (76.4)
Race
Non-White 42 (29.0) 34 (23.8) 12 (16.7)
White 103 (71.0) 109 (76.2) 60 (83.3)
Ethnicity
Hispanic 19 (13.2) 12 (8.5) 5 (7.0)
Non-Hispanic 125 (86.8) 130 (91.5) 66 (93.0)
Cancer
Type
Breast 66 (45.5) 67 (46.9) 32 (44.4)
Prostate 16 (11.0) 18 (12.6) 7 (9.7)
Lymphoma 22 (15.2) 19 (13.3) 10 (13.9)
Other 41 (28.3) 39 (27.2) 23 (32.0)
Previous treatments
Surgery 103 (71.0) 103 (72.0) 54 (75.0)
Chemotherapy 57 (39.3) 56 (39.2) 31 (43.1)
Radiation 75 (51.7) 78 (54.5) 35 (48.6)
Biological/immunotherapy 5 (3.4) 12 (8.4) 1 (1.4)
Hormonal 50 (34.5) 31 (21.7) 20 (27.8)
Years since cancer diagnosis, mean (SD) 6.1 (6.5) 6.1 (6.8) 6.5 (7.0)
Duration of pain, mean (SD), ya 5.7 (6.7) 4.8 (6.3) 5.5 (6.4)
Location of paina
Neck 14 (9.7) 15 (10.5) 6 (8.3)
Lower back 53 (36.6) 44 (30.8) 20 (27.8)
Shoulder/arm/elbow 15 (10.3) 24 (16.8) 6 (8.3)
Hip/thigh 16 (11.0) 17 (11.9) 9 (12.5)
Knee/leg 21 (14.5) 26 (18.2) 17 (23.6)
Other 26 (17.9) 17 (11.8) 14 (19.5)
Baseline measures
BPI pain severity score, mean (SD)b 5.2 (1.8) 5.0 (1.7) 5.6 (1.5)
BPI interference score, mean (SD)b 5.1 (2.4) 4.7 (2.2) 5.3 (2.2)
Taking any pain medicationsc 83 (58.5) 81 (59.6) 46 (66.7)

Abbreviation: BPI, Brief Pain Inventory.

a

Duration of pain symptoms and location of pain were reported by the patient and verified by clinicians before enrollment.

b

The BPI pain severity score (range, 0-10) was the mean of the 4 pain items. The BPI interference score (range, 0-10) was the mean of the 7 interference items.

c

Patients who were taking any pain medications at baseline.